Medication info

Kovir Tablet (Acyclovir)

Prescription medicationTabletIntravenous injection
Ingredient · strength
Acyclovir›200mg / 1 tablet
Manufacturer / importer
Joara Pharmaceutical Co., Ltd.
Appearance
Round light blue tablet
Packaging
30 tablets, 100 tablets
Approval status
Active

MFDS item code 201604021 · Approved 2016.06.28

Summary

Main use
Treatment and prevention of herpes simplex (including genital herpes), and treatment of herpes zoster and chickenpox in children
Who receives it
Adults · Children
Adult administration
○ Adults 1. Treatment of herpes simplex virus infections 1) Administer acyclovir 200 mg per dose 5 times daily at 4-hour intervals for 5 days. For severe initial infections, treatment may be extended. 2) In patients with severe immunocompromise (e.g., after bone marrow transplantation) or gastrointestinal malabsorption, the dose may be increased to 400 mg per administration or the route of administration may be changed to intravenous injection. 3) It is preferable to administer as soon as possible after infection; in recurrent cases, administer at the first appearance of prodromal symptoms or lesions. 2. Prevention of herpes simplex infections in patients with normal immune function 1) Administer this medicine 200 mg per dose 4 times daily at approximately 6-hour intervals. Alternatively, it may be administered as 400 mg per dose 2 times daily at 12-hour intervals. 2) Thereafter, the dose may be reduced to 200 mg per dose 2 ~ 3 times daily after confirming its efficacy. 3) To assess the natural course of the disease, patients receiving long-term treatment should periodically discontinue treatment every 6 ~ 12 months for evaluation. 3. Prevention of herpes simplex infections in immunocompromised patients 1) Administer this medicine 200 mg per dose 4 times daily at approximately 6-hour intervals. 2) In patients with severe immunocompromise (e.g., after bone marrow transplantation) or gastrointestinal malabsorption, the dose may be increased to 400 mg per administration or the route of administration may be changed to intravenous injection. 3) Administer during the period of risk of infection. 4. Treatment of herpes zoster 1) Administer this medicine 800 mg per dose 5 times daily at approximately 4-hour intervals, excluding bedtime, for a total of 7 days. 2) In patients with severe immunocompromise or gastrointestinal malabsorption, intravenous administration should be considered. 3) It is preferable to administer as soon as possible after infection; the earlier treatment is started, the better the effect. ○ Patients with renal impairment Patients with renal impairment are more prone to neuropsychiatric adverse reactions; therefore, use caution, including by extending the dosing interval or reducing the dose. 1. Treatment of herpes simplex infections The oral dose is generally not higher than the amount accumulated following intravenous administration. However, in patients with severe renal impairment (creatinine clearance less than 10 mL per minute), it is preferable to administer this medicine 200 mg every 12 hours. 2. Treatment of herpes zoster virus infections 1) In patients with creatinine clearance less than 10 mL per minute, it is preferable to reduce the dose of this medicine to 800 mg per dose 2 times daily, at approximately 12-hour intervals. 2) In patients with creatinine clearance of 10 ~ 25 mL per minute, it is preferable to reduce the dose of this medicine to 800 mg per dose 3 times daily, at approximately 8-hour intervals.
Child administration
Age 2 years and older: Same as for adults. Under 2 years: Administer 1/2 the adult dose. Treatment of chickenpox in children 2 years of age and older: Administer this medicine at 20 mg per kg of body weight per dose (maximum 800 mg per dose) 4 times daily for 5 days.

Ingredients

Manufacturer
Joara Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment and prevention of herpes simplex (including genital herpes), and treatment of herpes zoster and chickenpox in children

  • Genital herpes
  • herpes simplex virus infection
  • herpes zoster virus infection
  • acute pain
  • chickenpox
View approved original text

This medication is used to treat and prevent herpes simplex virus infections occurring on the skin and mucous membranes, including primary and recurrent genital herpes. It is also effective in treating herpes zoster virus infections, particularly for pain occurring during acute phases. However, the effectiveness against postherpetic neuralgia has not yet been clearly demonstrated. It can also be used to treat chickenpox in children aged 2 years and older. This drug is available in various forms (tablet, syrup, suspension) for convenient administration. Overall, it aids in the treatment of viral infections, improving patient symptoms.

How it is given

Adult administration

○ Adults 1. Treatment of herpes simplex virus infections 1) Administer acyclovir 200 mg per dose 5 times daily at 4-hour intervals for 5 days. For severe initial infections, treatment may be extended. 2) In patients with severe immunocompromise (e.g., after bone marrow transplantation) or gastrointestinal malabsorption, the dose may be increased to 400 mg per administration or the route of administration may be changed to intravenous injection. 3) It is preferable to administer as soon as possible after infection; in recurrent cases, administer at the first appearance of prodromal symptoms or lesions. 2. Prevention of herpes simplex infections in patients with normal immune function 1) Administer this medicine 200 mg per dose 4 times daily at approximately 6-hour intervals. Alternatively, it may be administered as 400 mg per dose 2 times daily at 12-hour intervals. 2) Thereafter, the dose may be reduced to 200 mg per dose 2 ~ 3 times daily after confirming its efficacy. 3) To assess the natural course of the disease, patients receiving long-term treatment should periodically discontinue treatment every 6 ~ 12 months for evaluation. 3. Prevention of herpes simplex infections in immunocompromised patients 1) Administer this medicine 200 mg per dose 4 times daily at approximately 6-hour intervals. 2) In patients with severe immunocompromise (e.g., after bone marrow transplantation) or gastrointestinal malabsorption, the dose may be increased to 400 mg per administration or the route of administration may be changed to intravenous injection. 3) Administer during the period of risk of infection. 4. Treatment of herpes zoster 1) Administer this medicine 800 mg per dose 5 times daily at approximately 4-hour intervals, excluding bedtime, for a total of 7 days. 2) In patients with severe immunocompromise or gastrointestinal malabsorption, intravenous administration should be considered. 3) It is preferable to administer as soon as possible after infection; the earlier treatment is started, the better the effect. ○ Patients with renal impairment Patients with renal impairment are more prone to neuropsychiatric adverse reactions; therefore, use caution, including by extending the dosing interval or reducing the dose. 1. Treatment of herpes simplex infections The oral dose is generally not higher than the amount accumulated following intravenous administration. However, in patients with severe renal impairment (creatinine clearance less than 10 mL per minute), it is preferable to administer this medicine 200 mg every 12 hours. 2. Treatment of herpes zoster virus infections 1) In patients with creatinine clearance less than 10 mL per minute, it is preferable to reduce the dose of this medicine to 800 mg per dose 2 times daily, at approximately 12-hour intervals. 2) In patients with creatinine clearance of 10 ~ 25 mL per minute, it is preferable to reduce the dose of this medicine to 800 mg per dose 3 times daily, at approximately 8-hour intervals.

Child administration

Age 2 years and older: Same as for adults. Under 2 years: Administer 1/2 the adult dose. Treatment of chickenpox in children 2 years of age and older: Administer this medicine at 20 mg per kg of body weight per dose (maximum 800 mg per dose) 4 times daily for 5 days.

Precautions

This medication should not be used by patients who are allergic to this drug or any of its ingredients or have experienced hypersensitivity reactions. Patients with impaired kidney function may be at higher risk for psychiatric symptoms when using this drug, so caution is required. Patients with liver dysfunction should use this medication cautiously as it may worsen liver function. Extra care is advised when administering this drug to infants and children, as elderly patients may also be more sensitive to side effects. This medication can rarely cause serious allergic reactions such as anaphylactic shock; if symptoms like hypotension, respiratory distress, or chest tightness occur, use should be discontinued immediately and medical assistance sought. Hypersensitivity reactions such as phototoxic reactions, rashes, fever, and urticaria may occur, warranting immediate discontinuation of the medication if such symptoms arise. Skin-related side effects like hair loss and severe skin inflammatory symptoms may appear, necessitating careful observation of skin conditions. Psychiatric symptoms such as confusion, hallucinations, seizures, drowsiness, anxiety, and dizziness may occur, especially in elderly patients and those with reduced kidney function, so caution is warranted. Kidney function impairments can arise, making it essential to regularly check kidney health. Hematologic and lymphatic abnormalities such as leukopenia, bleeding, and anemia may occur, so any unusual symptoms should be promptly reported. Liver dysfunction or symptoms of hepatitis and jaundice should be monitored closely. Gastrointestinal side effects like gastritis, vomiting, diarrhea, and abdominal pain can occur; if symptoms are severe, discontinuation of the medication and consultation is recommended. Adequate hydration is required during the use of this medication, particularly at high doses, to prevent dehydration and reduce the risk of kidney toxicity. The most effective time to administer this medication is at the onset of symptoms; if symptoms do not improve or worsen during treatment, alternative therapies should be considered. Activities involving driving or operating machinery may need caution, as consciousness impairment or drowsiness may occur. Interactions may occur when this drug is used with other medications, particularly those affecting kidney function or certain drugs, warranting careful monitoring. Women who are pregnant or may become pregnant should carefully consider the risks and benefits of using this medication, and breastfeeding should be stopped if using this drug. It should only be administered to infants and children when necessary, and caution should be exercised in neonates or low-birth-weight infants, as safety has not been established. Elderly patients may require dose adjustments due to prolonged drug presence in the body and should ensure sufficient hydration. In cases of overdose, kidney damage and neurological symptoms may occur; immediate medical assistance should be sought, and blood drug levels should be checked for appropriate treatment such as hemodialysis if necessary. High-dose administration of this drug may have genetic or reproductive effects; however, no significant effects have been reported at standard doses.

Side effects

  • Anaphylactic shock
  • anaphylactoid reactions
  • hypotension
  • dyspnea
  • chest tightness
  • photosensitivity reactions
  • fixed drug eruption
  • rash
  • fever
  • blisters
Show 117 more
  • urticarial erythema
  • urticaria
  • alopecia
  • erythema multiforme
  • Stevens-Johnson syndrome
  • toxic epidermal necrolysis
  • altered consciousness
  • disorientation
  • impaired concentration
  • aggressive behavior
  • depersonalization
  • agitation
  • ataxia
  • coma
  • confusion
  • delirium
  • stuttering
  • encephalopathy
  • hallucinations
  • psychosis
  • convulsions
  • drowsiness
  • tremors
  • excitement
  • forgetfulness
  • insomnia
  • anxiety
  • soliloquy
  • paresthesia
  • ataxia
  • inability to walk
  • involuntary movements
  • nystagmus
  • dizziness
  • renal failure
  • crystalluria
  • elevated BUN
  • elevated serum creatinine
  • hematuria
  • proteinuria
  • urinary red blood cell casts
  • pyuria
  • leukocyte-associated vasculitis
  • lymphadenopathy
  • bleeding
  • purpura
  • anemia
  • leukopenia
  • leukocytosis
  • eosinophilia
  • lymphocytosis
  • thrombocytosis
  • agranulocytosis
  • thrombocytopenia
  • basophilia
  • hepatitis
  • liver dysfunction
  • jaundice
  • abnormal liver function tests
  • hepatomegaly
  • gastritis
  • thirst
  • constipation
  • acute pancreatitis
  • diarrhea
  • soft stools
  • upper abdominal pain
  • stomach pain
  • abdominal pain
  • nausea
  • vomiting
  • dyspepsia
  • loss of appetite
  • glossitis
  • fever
  • peripheral edema
  • syncope
  • pallor
  • muscle weakness
  • malaise
  • generalized fatigue
  • headache
  • arthralgia
  • myalgia
  • arrhythmia
  • chest pain
  • hypertension
  • hypotension
  • tachycardia
  • palpitations
  • urinary obstruction
  • dysuria
  • glycosuria
  • pneumonia
  • pharyngitis
  • pleural effusion
  • pain
  • hearing loss
  • conjunctivitis
  • visual disturbances
  • taste disturbances
  • sweating
  • hyponatremia
  • hypoproteinemia
  • elevated total cholesterol levels
  • elevated triglyceride levels
  • elevated serum potassium levels
  • decreased serum albumin levels
  • agitation
  • coma
  • convulsions
  • lethargy
  • confusion
  • hallucinations
  • excitement
  • seizures
  • comatose state

Not everyone experiences these, and they can vary from person to person.

Storage

This medication is sensitive to light and should be stored in a container that blocks light. Additionally, it is important to store it at room temperature between 1 to 30 degrees Celsius to maintain its effectiveness.

Appearance and packaging

Appearance

Round light blue tablet

Package unit

30 tablets, 100 tablets

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.